PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,329,568 | +26.8% | 446,400 | +5.6% | 1.96% | -11.0% |
| Q1 2023 | $9,724,400 | +155.5% | 422,800 | +163.1% | 2.21% | +341.2% |
| Q1 2022 | $3,806,000 | -12.3% | 160,700 | +26.6% | 0.50% | -22.7% |
| Q4 2021 | $4,341,000 | +300.8% | 126,900 | +107.7% | 0.65% | +751.3% |
| Q3 2021 | $1,083,000 | -3.0% | 61,100 | -61.4% | 0.08% | -9.5% |
| Q1 2020 | $1,117,000 | +102.4% | 158,222 | +102.0% | 0.08% | -5.6% |
| Q4 2019 | $552,000 | – | 78,326 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |